NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test

Psychopharmacology

Volumn 206, Issue 2, 2009, Pages 325-333

  Ghasemi, Mehdi ^a   Montaser Kouhsari, Laleh ^a,c   Shafaroodi, Hamed ^b   Nezami, Behtash Ghazi ^a   Ebrahimi, Farzad ^a,c   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Depression; Forced swimming test; N methyl D aspartate (NMDA) antagonists; Nitric oxide; Nitric oxide synthase; Paroxetine

Indexed keywords

ANTIDEPRESSANT AGENT; ARGININE; DIZOCILPINE; IFENPRODIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PAROXETINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; IMMOBILITY RESPONSE, TONIC; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PAROXETINE; PIPERIDINES; RECEPTORS, N-METHYL-D-ASPARTATE; SWIMMING;

EID: 69549126138     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1609-1     Document Type: Article

References (84)

1. RC Almeida CS Felisbino MG Lopez AL Rodrigues NH Gabilan 2006 Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice Behav Brain Res 168 318 322
2. RC Almeida DG Souza RC Soletti MG Lopez AL Rodrigues NH Gabilan 2006 Involvement of PKA, MAPK/ERK and CaMKII, but not PKC in the acute antidepressant-like effect of memantine in mice Neurosci Lett 395 93 97
3. EL Altschuler RE Kast 2004 Paroxetine for hepatopulmonary syndrome? Med Hypotheses 62 446 447
4. IM Anderson 2000 Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability J Affect Disord 58 19 36
5. J Angulo C Peiro CF Sanchez-Ferrer S Gabancho P Cuevas S Gupta I Saenz de Tejada 2001 Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue Br J Pharmacol 134 1190 1194
6. C Ballus G Quiros T De Flores J de la Torre D Palao L Rojo M Gutierrez L Casais Y Riesgo 2000 The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia Int Clin Psychopharmacol 15 43 48
7. P Baumann 1996 Pharmacology and pharmacokinetics of citalopram and other SSRIs Int Clin Psychopharmacol 11 Suppl 1 5 11
8. M Bourin P Chue Y Guillon 2001 Paroxetine: a review CNS Drug Rev 7 25 47
9. HR Chaudhry Z Qureshi IA Tareen I Yazdani 2002 Efficacy and tolerability of paroxetine 20 mg daily in the treatment of depression and depression associated anxiety J Pak Med Assoc 52 518 525
10. F Chenu BP Guiard M Bourin AM Gardier 2006 Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test Behav Brain Res 172 256 263
11. W Chrapko P Jurasz MW Radomski SL Archer SC Newman G Baker N Lara JM Le Melledo 2006 Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients Neuropsychopharmacology 31 1286 1293
12. JL Claghorn A Kiev K Rickels WT Smith GC Dunbar 1992 Paroxetine versus placebo: a double-blind comparison in depressed patients J Clin Psychiatry 53 434 438
13. JF Cryan A Markou I Lucki 2002 Assessing antidepressant activity in rodents: recent developments and future needs Trends Pharmacol Sci 23 238 245
14. MP Cunha DG Machado LE Bettio JC Capra AL Rodrigues 2008 Interaction of zinc with antidepressants in the tail suspension test Prog Neuropsychopharmacol Biol Psychiatry 32 1913 1920
15. GD da Silva AS Matteussi AR dos Santos JB Calixto AL Rodrigues 2000 Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice Neuroreport 11 3699 3702
16. DJ David BA Nic Dhonnchadha P Jolliet M Hascoet M Bourin 2001 Are there gender differences in the temperature profile of mice after acute antidepressant administration and exposure to two animal models of depression? Behav Brain Res 119 203 211
17. DJP David CE Renard P Jolliet M Hascoet M Bourin 2003 Antidepressant-like effects in various mice strains in the forced swimming test Psychopharmacology 166 373 382 (Pubitemid 36503032)
18. GJ Emslie KD Wagner S Kutcher S Krulewicz R Fong DJ Carpenter A Lipschitz A Machin C Wilkinson 2006 Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial J Am Acad Child Adolesc Psychiatry 45 709 719
19. JV Esplugues 2002 NO as a signalling molecule in the nervous system Br J Pharmacol 135 1079 1095
20. MS Finkel F Laghrissi-Thode BG Pollock J Rong 1996 Paroxetine is a novel nitric oxide synthase inhibitor Psychopharmacol Bull 32 653 658
21. J Garthwaite 1991 Glutamate, nitric oxide and cell-cell signalling in the nervous system Trends Neurosci 14 60 67
22. J Garthwaite 1998 NO particular place to go Nature 395 133 134
23. M Ghasemi H Sadeghipour A Mosleh HR Sadeghipour AR Mani AR Dehpour 2008 Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test Eur Neuropsychopharmacol 18 323 332
24. Ghasemi M, Raza M, Dehpour AR (2009a) NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test. J Psychopharmacol (in press)
25. M Ghasemi H Sadeghipour G Poorheidari AR Dehpour 2009 A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test Behav Brain Res 200 76 82
26. Danish University Antidepressant Group 1990 Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study J Affect Disord 18 289 299
27. MR Hara SH Snyder 2007 Cell signaling and neuronal death Annu Rev Pharmacol Toxicol 47 117 141
28. AJ Harkin KH Bruce B Craft IA Paul 1999 Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test Eur J Pharmacol 372 207 213
29. A Harkin TJ Connor MP Burns JP Kelly 2004 Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test Eur Neuropsychopharmacol 14 274 281
30. J Hyttel 1994 Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs) Int Clin Psychopharmacol 9 Suppl 1 19 26
31. SY Inan I Yalcin F Aksu 2004 Dual effects of nitric oxide in the mouse forced swimming test: possible contribution of nitric oxide-mediated serotonin release and potassium channel modulation Pharmacol Biochem Behav 77 457 464
32. JP Jacobsen EO Nielsen R Hummel JP Redrobe N Mirza P Weikop 2008 Insensitivity of NMRI mice to selective serotonin reuptake inhibitors in the tail suspension test can be reversed by co-treatment with 5-hydroxytryptophan Psychopharmacology (Berl) 199 137 150
33. D Jefferys J Funder 1996 Nitric oxide modulates retention of immobility in the forced swimming test in rats Eur J Pharmacol 295 131 135
34. J Karatinos RB Rosse SI Deutsch 1995 The nitric oxide pathway: potential implications for treatment of neuropsychiatric disorders Clin Neuropharmacol 18 482 499
35. MP Kaster PK Ferreira AR Santos AL Rodrigues 2005 Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway Behav Brain Res 165 204 209
36. MB Keller ND Ryan M Strober RG Klein SP Kutcher B Birmaher OR Hagino H Koplewicz GA Carlson GN Clarke GJ Emslie D Feinberg B Geller V Kusumakar G Papatheodorou WH Sack M Sweeney KD Wagner EB Weller NC Winters R Oakes JP McCafferty 2001 Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial J Am Acad Child Adolesc Psychiatry 40 762 772
37. RC Kessler KR Merikangas PS Wang 2007 Prevalence, comorbidity, and severe utilization for mood disorders in the United States at the beginning of the twenty-first century Annu Rev Clin Psychol 3 137 158
38. J Kiecolt-Glaser R Glaser 2002 Depression and immune function: central pathways to morbidity and mortality J Psychosom Res 53 873
39. T Kos P Popik 2005 A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice Behav Pharmacol 16 155 161
40. N Lara SL Archer GB Baker JM Le Melledo 2003 Paroxetine-induced increase in metabolic end products of nitric oxide J Clin Psychopharmacol 23 641 645 (Pubitemid 37443193)
41. AJ Law JF Deakin 2001 Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses Neuroreport 12 2971 2974
42. RT Layer P Popik T Olds P Skolnick 1995 Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715) Pharmacol Biochem Behav 52 621 627
43. I Lucki A Dalvi AJ Mayorga 2001 Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice Psychopharmacology (Berl) 155 315 322
44. J Maj Z Rogoz G Skuza 1992 The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats Pol J Pharmacol Pharm 44 217 226
45. J Maj Z Rogoz G Skuza H Sowinska 1992 The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist Neuropharmacology 31 685 691
46. J Maj Z Rogoz G Skuza H Sowinska 1992 Effects of MK-801 and antidepressant drugs in the forced swimming test in rats Eur Neuropsychopharmacol 2 37 41
47. S Moncada RMJ Palmer EA Higgs 1991 Nitric oxide: physiology, pathophysiology and pharmacology Pharmacol Rev 43 109 142
48. O Mutlu G Ulak A Laugeray C Belzung 2008 Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice Pharmacol Biochem Behav 92 82 87
49. CB Nemeroff 1993 Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression J Clin Psychopharmacol 13 10S 17S
50. MK Nixon M Hascoet M Bourin MC Colombel 1994 Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system Psychopharmacology (Berl) 115 59 64
51. G Nowak GA Ordway IA Paul 1995 Alterations in the N-methyl-d-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims Brain Res 675 157 164
52. MF O'Neill AG Fernandez JM Palacios 1996 GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test Pharmacol Biochem Behav 53 535 539
53. JC Owen PS Whitton 2005 Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular 5-HT in the frontal cortex of freely moving rats Br J Pharmacol 145 587 592
54. E Panconi J Roux M Altenbaumer S Hampe RD Porsolt 1993 MK-801 and enantiomers: potential antidepressants or false positives in classical screening models? Pharmacol Biochem Behav 46 15 20
55. IA Paul P Skolnick 2003 Glutamate and depression: clinical and preclinical studies Ann N Y Acad Sci 1003 250 272
56. IA Paul G Nowak RT Layer P Popik P Skolnick 1994 Adaptation of the N-methyl-d-aspartate receptor complex following chronic antidepressant treatments J Pharmacol Exp Ther 269 95 102
57. G Perrault E Morel B Zivkovic DJ Sanger 1992 Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice Pharmacol Biochem Behav 42 45 47
58. RX Petrie IC Reid CA Stewart 2000 The N-methyl-d-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review Pharmacol Ther 87 11 25
59. RD Porsolt A Bertin M Jalfre 1977 Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 327 336
60. C Prica M Hascoet M Bourin 2008 Is co-administration of bupropion with SSRIs and SNRIs in forced swimming test in mice, predictive of efficacy in resistant depression? Behav Brain Res 194 92 99
61. MH Rapaport LS Schneider DL Dunner JT Davies CD Pitts 2003 Efficacy of controlled-release paroxetine in the treatment of late-life depression J Clin Psychiatry 64 1065 1074
62. JP Redrobe M Bourin 1998 Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test Psychopharmacology (Berl) 138 198 206
63. JP Redrobe M Bourin MC Colombel GB Baker 1998 Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms J Psychopharmacol 12 348 355
64. N Ripoll DJ David E Dailly M Hascoet M Bourin 2003 Antidepressant-like effects in various mice strains in the tail suspension test Behav Brain Res 143 193 200 (Pubitemid 36937164)
65. Z Rogoz G Skuza J Maj W Danysz 2002 Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats Neuropharmacology 42 1024 1030
66. Z Rogoz D Dlaboga M Dziedzicka-Wasylewska 2003 Effect of combined treatment with imipramine and amantadine on the central dopamine D2 and D3 receptors in rats J Physiol Pharmacol 54 257 270
67. Z Rogoz G Skuza M Kusmider J Wojcikowski M Kot WA Daniel 2004 Synergistic effect of imipramine and amantadine in the forced swimming test in rats. Behavioral and pharmacokinetic studies Pol J Pharmacol 56 179 185
68. AO Rosa J Lin JB Calixto AR Santos AL Rodrigues 2003 Involvement of NMDA receptors and l-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice Behav Brain Res 144 87 93
69. C Sanchez E Meier 1997 Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike? Psychopharmacology (Berl) 129 197 205
70. E Suzuki G Yagi T Nakaki S Kanba M Asai 2001 Elevated plasma nitrate levels in depressive states J Affect Disord 63 221 224
71. E Tatarczynska A Klodzinska E Chojnacka-Wojcik 2002 Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats Pol J Pharmacol 54 615 623
72. ME Thase 2007 Molecules that mediate mood N Engl J Med 357 2400 2402
73. DR Thomas DR Nelson AM Johnson 1987 Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor Psychopharmacology (Berl) 93 193 200
74. R Trullas P Skolnick 1990 Functional antagonists at the NMDA receptor complex exhibit antidepressant actions Eur J Pharmacol 185 1 10 (Pubitemid 20254891)
75. R Trullas T Folio A Young R Miller K Boje P Skolnick 1991 1-Aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models Eur J Pharmacol 203 379 385
76. G Ulak O Mutlu FY Akar FI Komsuoǧlu P Tanyeri BF Erden 2008 Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats Phamacol Biocem Behav 90 563 568
77. J van Harten 1993 Clinical pharmacokinetics of selective serotonin reuptake inhibitors Clin Pharmacokinet 24 203 220
78. JM Vaugeois G Passera F Zuccaro J Costentin 1997 Individual differences in response to imipramine in the mouse tail suspension test Psychopharmacology (Berl) 134 387 391
79. G Wegener V Volke BH Harvey R Rosenberg 2003 Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity Brain Res 959 128 134
80. I Weiner D Schiller I Gaisler-Salomon A Green D Joel 2003 A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine Behav Pharmacol 14 215 222
81. KM Wicke A Rex A Jongen-Relo I Groth G Gross 2007 The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants Psychopharmacology (Berl) 195 95 102
82. T Yamamoto S Shibata T Shimazoe K Iwasaki M Ohno Y Minamoto Y Furuya K Miyamoto S Watanabe S Ueki 1989 Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor Nippon Yakurigaku Zasshi 94 189 206
83. F Yildiz BF Erden G Ulak T Utkan N Gacar 2000 Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats Psychopharmacology 149 41 44
84. KA Yonkers H Lin HB Howell AC Heath LS Cohen 2008 Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine J Clin Psychiatry 69 659 665